Status:
UNKNOWN
The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau
Lead Sponsor:
Bandim Health Project
Conditions:
Malaria
Falciparum
Eligibility:
All Genders
Up to 15 years
Phase:
PHASE4
Brief Summary
The National Malaria Programme in Guinea-Bissau recommends paracetamol for all children treated for malaria. We, the investigators of the Bandim Health Project, want to evaluate whether this treatment...
Detailed Description
A Cochrane Review was unable to show a superior antipyretic effect of paracetamol compared with placebo in febrile children. Recent research suggests that the time to parasite clearance in non-severe ...
Eligibility Criteria
Inclusion
- \< 15 years of age
- Presenting at Bandim Health Centre
- Symptoms suggestive of malaria
- At least 20 P. falciparum parasites per 200 leukocytes
- Live in Bandim (to enable follow-up)
Exclusion
- Severely ill children considered to need the services of a hospital by the doctor in charge
- Previous idiosyncratic reactions to chloroquine or paracetamol
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
End Date :
January 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00137566
Start Date
May 1 2004
End Date
January 1 2010
Last Update
July 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Apartado 861, Bissau Region, Guinea-Bissau